EDWARDS LIFESCIENCES CORP (EWL.DE) Fundamental Analysis & Valuation

FRA:EWL • US28176E1082

Current stock price

72.1 EUR
+3.92 (+5.75%)
Last:

This EWL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. EWL.DE Profitability Analysis

1.1 Basic Checks

  • EWL had positive earnings in the past year.
  • EWL had a positive operating cash flow in the past year.
  • EWL had positive earnings in each of the past 5 years.
  • Each year in the past 5 years EWL had a positive operating cash flow.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • EWL's Return On Assets of 7.84% is amongst the best of the industry. EWL outperforms 87.93% of its industry peers.
  • With a decent Return On Equity value of 10.38%, EWL is doing good in the industry, outperforming 72.41% of the companies in the same industry.
  • EWL's Return On Invested Capital of 12.01% is amongst the best of the industry. EWL outperforms 86.21% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 9.41%.
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROIC 12.01%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 17.69%, EWL belongs to the best of the industry, outperforming 93.10% of the companies in the same industry.
  • EWL's Profit Margin has been stable in the last couple of years.
  • With an excellent Operating Margin value of 27.17%, EWL belongs to the best of the industry, outperforming 94.83% of the companies in the same industry.
  • In the last couple of years the Operating Margin of EWL has declined.
  • EWL's Gross Margin of 78.01% is amongst the best of the industry. EWL outperforms 91.38% of its industry peers.
  • In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
Industry RankSector Rank
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. EWL.DE Health Analysis

2.1 Basic Checks

  • EWL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, EWL has less shares outstanding
  • Compared to 5 years ago, EWL has less shares outstanding
  • EWL has a better debt/assets ratio than last year.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 10.95 indicates that EWL is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 10.95, EWL belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
  • EWL has a debt to FCF ratio of 0.45. This is a very positive value and a sign of high solvency as it would only need 0.45 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.45, EWL belongs to the top of the industry, outperforming 94.83% of the companies in the same industry.
  • EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • EWL's Debt to Equity ratio of 0.06 is amongst the best of the industry. EWL outperforms 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Altman-Z 10.95
ROIC/WACC1.36
WACC8.86%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • EWL has a Current Ratio of 3.72. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • EWL has a better Current ratio (3.72) than 89.66% of its industry peers.
  • EWL has a Quick Ratio of 3.09. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • EWL has a Quick ratio of 3.09. This is amongst the best in the industry. EWL outperforms 91.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.72
Quick Ratio 3.09
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. EWL.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.85% over the past year.
  • Measured over the past 5 years, EWL shows a small growth in Earnings Per Share. The EPS has been growing by 6.67% on average per year.
  • EWL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.55%.
  • EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)3.85%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%21.88%
Revenue 1Y (TTM)11.55%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%16.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.89% on average over the next years. This is quite good.
  • EWL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.72% yearly.
EPS Next Y17.69%
EPS Next 2Y14.79%
EPS Next 3Y14.05%
EPS Next 5Y12.89%
Revenue Next Year10.66%
Revenue Next 2Y10.24%
Revenue Next 3Y10.15%
Revenue Next 5Y9.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. EWL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 31.21, which means the current valuation is very expensive for EWL.
  • EWL's Price/Earnings is on the same level as the industry average.
  • EWL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.35, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.03 indicates a quite expensive valuation of EWL.
  • EWL's Price/Forward Earnings ratio is in line with the industry average.
  • EWL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.23, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.21
Fwd PE 25.03
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EWL is valued a bit more expensive than 63.79% of the companies in the same industry.
  • EWL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 36.47
EV/EBITDA 22.78
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • EWL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • EWL has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as EWL's earnings are expected to grow with 14.05% in the coming years.
PEG (NY)1.76
PEG (5Y)4.68
EPS Next 2Y14.79%
EPS Next 3Y14.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EWL.DE Dividend Analysis

5.1 Amount

  • EWL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EWL.DE Fundamentals: All Metrics, Ratios and Statistics

EDWARDS LIFESCIENCES CORP

FRA:EWL (4/27/2026, 7:00:00 PM)

72.1

+3.92 (+5.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-23
Earnings (Next)07-22
Inst Owners92.06%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap41.57B
Revenue(TTM)6.07B
Net Income(TTM)1.07B
Analysts79.53
Price Target82.95 (15.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.39%
Min EPS beat(2)-8.84%
Max EPS beat(2)9.63%
EPS beat(4)3
Avg EPS beat(4)2.32%
Min EPS beat(4)-8.84%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)1.48%
EPS beat(12)5
Avg EPS beat(12)0.35%
EPS beat(16)7
Avg EPS beat(16)-0.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.84%
Revenue beat(12)2
Avg Revenue beat(12)-2.11%
Revenue beat(16)2
Avg Revenue beat(16)-2.28%
PT rev (1m)1.64%
PT rev (3m)-1.95%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)5.99%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)1.78%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)1.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 31.21
Fwd PE 25.03
P/S 8.02
P/FCF 36.47
P/OCF 30.52
P/B 4.71
P/tB 6.54
EV/EBITDA 22.78
EPS(TTM)2.31
EY3.2%
EPS(NY)2.88
Fwd EY3.99%
FCF(TTM)1.98
FCFY2.74%
OCF(TTM)2.36
OCFY3.28%
SpS8.99
BVpS15.31
TBVpS11.02
PEG (NY)1.76
PEG (5Y)4.68
Graham Number28.2083 (-60.88%)
Profitability
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROCE 13.87%
ROIC 12.01%
ROICexc 18.64%
ROICexgc 29.98%
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
FCFM 22%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
ROICexc(3y)18.54%
ROICexc(5y)20.56%
ROICexgc(3y)28.25%
ROICexgc(5y)29.44%
ROCE(3y)15.07%
ROCE(5y)17.95%
ROICexgc growth 3Y0.42%
ROICexgc growth 5Y-1.8%
ROICexc growth 3Y-6.11%
ROICexc growth 5Y-3.98%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Debt/EBITDA 0.33
Cap/Depr 166.16%
Cap/Sales 4.29%
Interest Coverage 81.62
Cash Conversion 88.36%
Profit Quality 124.36%
Current Ratio 3.72
Quick Ratio 3.09
Altman-Z 10.95
F-Score6
WACC8.86%
ROIC/WACC1.36
Cap/Depr(3y)177.3%
Cap/Depr(5y)193.25%
Cap/Sales(3y)4.93%
Cap/Sales(5y)5.41%
Profit Quality(3y)58.49%
Profit Quality(5y)66.28%
High Growth Momentum
Growth
EPS 1Y (TTM)3.85%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%21.88%
EPS Next Y17.69%
EPS Next 2Y14.79%
EPS Next 3Y14.05%
EPS Next 5Y12.89%
Revenue 1Y (TTM)11.55%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%16.7%
Revenue Next Year10.66%
Revenue Next 2Y10.24%
Revenue Next 3Y10.15%
Revenue Next 5Y9.72%
EBIT growth 1Y11.04%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year25.82%
EBIT Next 3Y16.1%
EBIT Next 5Y14.45%
FCF growth 1Y413.66%
FCF growth 3Y11.88%
FCF growth 5Y15.59%
OCF growth 1Y194.16%
OCF growth 3Y9.4%
OCF growth 5Y8.64%

EDWARDS LIFESCIENCES CORP / EWL.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


How profitable is EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


Can you provide the financial health for EWL stock?

The financial health rating of EDWARDS LIFESCIENCES CORP (EWL.DE) is 10 / 10.